LIQUIDIA CORPORATION (LQDA) Debt Components
- 2022-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $19.88M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2022-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $19.88M; Long-Term Debt, Maturity, Year TwoUSD (m).
- 2022-09-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $19.74M; Long-term DebtUSD $19.74M; Long-Term Debt, Maturity, Year TwoUSD $10.00M.
- 2022-06-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $19.61M; Long-term DebtUSD $19.61M; Long-Term Debt, Maturity, Year TwoUSD $10.00M.
LIQUIDIA CORPORATION Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | (m) | $19.88M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $19.88M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $19.74M | $19.74M | $10.00M | $10.00M | $20.00M | $259.00K |
| 2022-06-30 | (m) | $19.61M | $19.61M | $10.00M | $10.00M | $20.00M | $394.00K |
| 2022-03-31 | (m) | $19.48M | $19.48M | $10.00M | $10.00M | $20.00M | $524.00K |
| 2021-12-31 | (m) | $10.41M | $10.41M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $10.33M | (m) | $5.25M | $5.25M | $10.50M | $168.35K |
| 2021-06-30 | (m) | $10.25M | $10.25M | $5.25M | $5.25M | $10.50M | $246.17K |
| 2021-03-31 | (m) | $10.18M | $10.18M | $5.25M | $5.25M | $10.50M | $323.52K |
| 2020-12-31 | (m) | $10.29M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $10.29M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $5.59M | $10.29M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |